TEST BANK Pharmacology and the Nursing Process 9th Edition Linda Lane Lilley.

Page 212

Chapter 39: Antibiotics Part 2

Chapter 39: Antibiotics Part 2 MULTIPLE CHOICE 1. When a patient is on aminoglycoside therapy, the nurse will monitor the patient for which

indicators of potential toxicity? a. Fever b. White blood cell count of 8000 cells/mm3 c. Tinnitus and dizziness d. Decreased blood urea nitrogen (BUN) levels ANS: C

Dizziness, tinnitus, hearing loss, or a sense of fullness in the ears could indicate ototoxicity, a potentially serious toxicity in a patient. Nephrotoxicity is indicated by rising blood urea nitrogen and creatinine levels. Fever may be indicative of the patient’s infection; a white blood cell count of 7000 cells/mm3 is within the normal range of 5000 to 10,000 cells/mm3. DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Evaluation MSC: NCLEX: Physiological Integrity: Reduction of Risk Potential 2. The nurse is administering a vancomycin (Vancocin) infusion. Which measure is appropriate for

the nurse to implement in order to reduce complications that may occur with this drug’s administration? a. Monitoring blood pressure for hypertension during the infusion b. Discontinuing the drug immediately if red man syndrome occurs c. Restricting fluids during vancomycin therapy d. Infusing the drug over at least 1 hour ANS: D

Infuse the medication over at least 1 hour to reduce the occurrence of red man syndrome. Adequate hydration (at least 2 L of fluid in 24 hours) during vancomycin therapy is important for the prevention of nephrotoxicity. Hypotension may occur during the infusion, especially if it is given too rapidly. DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Implementation MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies 3. Which nursing diagnosis is appropriate for a patient who has started aminoglycoside therapy? a. Constipation b. Risk for injury (renal damage) c. Disturbed body image related to gynecomastia d. Imbalanced nutrition, less than body requirements, related to nausea ANS: B

Patients on aminoglycoside therapy have an increased risk for injury caused by nephrotoxicity. The other options are incorrect.

211


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Chapter 56: Dermatologic Drugs

18min
pages 305-318

Chapter 55: Nutritional Supplements

4min
pages 300-304

Chapter 54: Anemia Drugs

7min
pages 293-299

Chapter 52: Antiemetic and Antinausea Drugs

13min
pages 282-292

Chapter 51: Bowel Disorder Drugs

8min
pages 275-281

Chapter 48: Immunosuppressant Drugs

18min
pages 259-274

Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs

5min
pages 254-258

Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell

12min
pages 243-253

Chapter 44: Anti-inflammatory and Antigout Drugs

6min
pages 237-242

Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs

5min
pages 232-236

Chapter 42: Antifungal Drugs

6min
pages 227-231

Chapter 41: Antitubercular Drugs

6min
pages 222-226

Chapter 39: Antibiotics Part 2

12min
pages 212-221

Chapter 38: Antibiotics Part 1

8min
pages 205-211

Chapter 37: Respiratory Drugs

7min
pages 199-204

Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants

5min
pages 194-198

Chapter 35: Men’s Health Drugs

4min
pages 189-193

Chapter 34: Women’s Health Drugs

8min
pages 182-188

Chapter 27: Antilipemic Drugs

43min
pages 144-181

Chapter 26: Coagulation Modifier Drugs

7min
pages 138-143

Chapter 25: Antidysrhythmic Drugs

6min
pages 132-137

Chapter 24: Heart Failure Drugs

6min
pages 126-131

Chapter 23: Antianginal Drugs

7min
pages 120-125

Chapter 22: Antihypertensive Drugs

7min
pages 114-119

Chapter 19: Adrenergic-Blocking Drugs

17min
pages 99-113

Chapter 17: Substance Use Disorder

10min
pages 89-98

Chapter 16: Psychotherapeutic Drugs

8min
pages 82-88

Chapter 15: Antiparkinson Drugs

5min
pages 77-81

Chapter 13: Central Nervous System Stimulants and Related Drugs

12min
pages 67-76

Chapter 12: Central Nervous System Depressants and Muscle Relaxants

6min
pages 62-66

Chapter 09: Photo Atlas of Drug Administration

25min
pages 42-61

Chapter 06: Patient Education and Drug Therapy

14min
pages 30-41

Chapter 05: Medication Errors: Preventing and Responding

4min
pages 27-29

Chapter 04: Cultural, Legal, and Ethical Considerations

7min
pages 21-26

Chapter 03: Lifespan Considerations

8min
pages 15-20

Chapter 02: Pharmacologic Principles

8min
pages 9-14

Chapter 01: The Nursing Process and Drug Therapy

5min
pages 5-8
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.